NASDAQ:AKTX

Akari Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy AKTX

*Your capital is at risk

$14.99

+0.355 (+2.43%)

At Close: Jun 03, 2026

Akari Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 25.2M and sold 0 AKTX shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	100.00
● Buy	25.2M shares
● Sell	0 shares
100% Buy Activity Weak Negative Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Dec 16, 2025 Buy	Warrants to purchase ADRs P-Purchase	Neal James R Director	Director	3 093 Value: $1K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Neal James R Director	Director	3 093 Value: $31.4K
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Neal James R Director	Director	2 473 Value: $960
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Neal James R Director	Director	2 473 Value: $25.1K
Dec 16, 2025 Buy	Warrants to purchase ADRs P-Purchase	Bazemore Robert B Director	Director	30 932 Value: $12.0K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Bazemore Robert B Director	Director	30 932 Value: $313.8K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Bazemore Robert B Director	Director	123 731 Value: $1.26M
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Bazemore Robert B Director	Director	123 731 Value: $48.0K
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Gaslightwala Abizer CEO	CEO / President	309 328 Value: $120.1K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Gaslightwala Abizer CEO	CEO / President	309 328 Value: $3.14M
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Gaslightwala Abizer CEO	CEO / President	773 323 Value: $7.84M
Dec 16, 2025 Buy	Warrants to purchase ADRs P-Purchase	Gaslightwala Abizer CEO	CEO / President	773 323 Value: $300.3K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Patel Samir Rashmikant	Director	231 997 Value: $2.35M
Dec 16, 2025 Buy	Warrants to purchase ADRs P-Purchase	Patel Samir Rashmikant	Director	231 997 Value: $90.1K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Patel Samir Rashmikant	Director	618 658 Value: $6.28M
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Patel Samir Rashmikant	Director	618 658 Value: $240.2K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Farag Kameel D. Interim CFO	C-Suite Officer	24 745 Value: $251.0K
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Farag Kameel D. Interim CFO	C-Suite Officer	24 745 Value: $10K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Huh Hoyoung	Director	618 658 Value: $6.28M
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Huh Hoyoung	Director	618 658 Value: $240.2K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Huh Hoyoung	Director	3 093 293 Value: $31.4M
Dec 16, 2025 Buy	Warrants to purchase American Depositary Shares ("ADRs") P-Purchase	Prudo-chlebosz Raymond Director	Director	618 658 Value: $240.2K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Prudo-chlebosz Raymond Director	Director	618 658 Value: $6.28M
Dec 16, 2025 Buy	Warrants to purchase ADRs P-Purchase	Prudo-chlebosz Raymond Director	Director	386 661 Value: $150.1K
Dec 16, 2025 Buy	Pre-Funded Warrants to purchase ADRs P-Purchase	Prudo-chlebosz Raymond Director	Director	386 661 Value: $3.92M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT AKARI THERAPEUTICS PLC

Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ...

Read Full Profile Here